New Medication for Glioblastoma Tumors Holds Promise
Researchers at the Massachusetts General Hospital Cancer Center have discovered that a drug called AZD2171 can significantly reduce the size of glioblastoma brain tumors and that it can also help reduce swelling in the brain.
The study comprised 16 patients who took the drug daily, by mouth. Tumors began to shrink within 28 days. For some patients, the tumors shrank by 25 percent; for others, the tumors shrank by as much as 50 percent.
It's too early to know whether this drug will have an effect on overall survival rate. But it's important because patients with glioblastoma tumors are in great need of new medications for the times when their tumor growth recurs, or even for initial glioblastoma treatment.
Cancer Cell, January 2007